Stephen Flores, MD
Sports Medicine · Lubbock, TXNPI 1467779207
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.1%), education and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Rattan And Associates at 29.9% of the total. Reporting peaked in 2022 at $1,684 and has fallen 80.8% since, to $323 in 2025.
Across 61 payments — averaging $70.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rattan And Associates$1K
- Stryker$730
- DJO, LLC$687
- Zimmer Biomet$504
- Arthrex$219
- Vericel Corporation$124
- plus $749 from 15 others
What the payments were for
- Speaking & faculty fees$140%
- Travel & lodging$1,01824%
- Food & beverage$2,06948%
- Education$1,20028%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rattan And Associates | 3 | $1,287 |
| Stryker | 8 | $730 |
| DJO, LLC | 4 | $687 |
| Zimmer Biomet | 4 | $504 |
| Arthrex | 12 | $219 |
| Vericel Corporation | 3 | $124 |
| Si-bone, Inc. | 3 | $122 |
| Smith+Nephew | 3 | $118 |
| Bioventus LLC | 4 | $94 |
| FX Shoulder Solutions, Inc | 2 | $78 |
| Johnson & Johnson | 3 | $69 |
| Anika Therapeutics, Inc. | 1 | $65 |
| Pacira Therapeutics, Inc. | 3 | $48 |
| Abbott | 1 | $31 |
| Amgen | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Merck | 1 | $19 |
| Baudax Bio Inc. | 1 | $18 |
| Orthofix Medical, Inc. | 1 | $17 |
| Acacia Pharma Inc | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,300 in reported general payments places this provider in the 60th percentile of 437 sports medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 181 | $2,435 |
| Diclofenac Sodium | 30 | $751 |
| Ondansetron Hcl | 97 | $388 |
| Meloxicam | 128 | $359 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 39 | $345 |
| Tramadol Hcl | 54 | $187 |
| Gabapentin | 15 | $181 |
| Cephalexin | 15 | $116 |
| Celecoxib | 13 | $86 |
| Cyclobenzaprine Hcl | 14 | $62 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Lubbock
- Thomas DeberardinoSan Antonio$3.5M
- Robert ScheinbergDallas$2.2M
- Walter LoweHouston$1.4M
- Reed BartzSunnyvale$1.2M
- James GregoryHouston$565K
- John McDonaldAustin$499K
- James McKinleyTyler$305K
- Kelechi OkorohaDallas$297K
- Leon PaulosPearland$289K
- Marc LabbeThe Woodlands$238K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.